30
Participants
Start Date
October 31, 2005
Primary Completion Date
May 31, 2009
Study Completion Date
April 30, 2012
1.25 mg enalaprilat IV
an angiotensin converting enzyme (ACE) inhibitor given to lower blood pressure (BP) and measure cerebral blood flow (CBF)
Head up tilt (HUT)
45 degree head-up tilt to lower blood pressure and measure cerebral blood flow.
VA Medical Center, Bronx, The Bronx
VA Office of Research and Development
FED